Epigenetically altered miR-193b targets cyclin D1 in prostate cancer

Por Kaukoniemi, Kirsi M, Rauhala, Hanna E, Scaravilli, Mauro, Latonen, Leena, Annala, Matti, Vessella, Robert L, Nykter, Matti, Tammela, Teuvo L J, Visakorpi, Tapio
Publicado no Cancer Med (2015)

Myc-dependent purine biosynthesis affects nucleolar stress and therapy response in prostate cancer

Por Barfeld, Stefan J., Fazli, Ladan, Persson, Margareta, Marjavaara, Lisette, Urbanucci, Alfonso, Kaukoniemi, Kirsi M., Rennie, Paul S., Ceder, Yvonne, Chabes, Andrei, Visakorpi, Tapio, Mills, Ian G.
Publicado no Oncotarget (2015)

Recurrent SKIL-activating rearrangements in ETS-negative prostate cancer

Por Annala, Matti, Kivinummi, Kati, Tuominen, Joonas, Karakurt, Serdar, Granberg, Kirsi, Latonen, Leena, Ylipää, Antti, Sjöblom, Liisa, Ruusuvuori, Pekka, Saramäki, Outi, Kaukoniemi, Kirsi M., Yli-Harja, Olli, Vessella, Robert L., Tammela, Teuvo L.J, Zhang, Wei, Visakorpi, Tapio, Nykter, Matti
Publicado no Oncotarget (2015)